Ads
related to: Enbrel- Share Your COSENTYX Story
If You're Taking COSENTYX, Learn
How You Can Share Your Story.
- COSENTYX® Connect
Sign Up Today for Real
Support & Personal Solutions.
- Doctor Discussion Guide
Questions to Ask Before Seeing Your
Doctor to Talk About Treatment.
- How To Inject COSENTYX
Help Make Injecting Easier With
Injection Videos & Resources.
- Share Your COSENTYX Story
Search results
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 1 day agoPrevnar sales inched 2% ahead to $6.44 billion. But other key products saw downfalls. Revenue from...
Are your prescription drugs affordable? Colorado board wants feedback on these 2
KDVR Denver via Yahoo News· 2 days agoThe body was created in 2021 to review prescription drugs and evaluate their affordability for...
Mutual of America Capital Management LLC Cuts Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 6 days agoMutual of America Capital Management LLC lessened its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.3% in the 4th quarter, according to the company in its most recent 13F filing with ...
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 3 days agoIt aims to develop or acquire lower-risk, less splashy drugs it knows it can market. Underscoring...
TD Cowen Lowers Amgen (NASDAQ:AMGN) Price Target to $360.00
ETF DAILY NEWS· 17 hours agoAmgen (NASDAQ:AMGN – Get Free Report) had its price target dropped by TD Cowen from $370.00 to $360.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has a ...
Biogen (NASDAQ:BIIB) Price Target Cut to $214.00
ETF DAILY NEWS· 19 hours agoBiogen (NASDAQ:BIIB – Get Free Report) had its price target reduced by equities research analysts at UBS Group from $250.00 to $214.00 in a research note issued on Wednesday, Benzinga reports ...
Wedbush Lowers Biogen (NASDAQ:BIIB) Price Target to $213.00
ETF DAILY NEWS· 18 hours agoBiogen (NASDAQ:BIIB – Get Free Report) had its price target decreased by equities research analysts at Wedbush from $245.00 to $213.00 in a research report issued to clients and investors on ...
Biogen Inc. (NASDAQ:BIIB) Short Interest Update
ETF DAILY NEWS· 5 days agoBiogen Inc. (NASDAQ:BIIB – Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 3,550,000 ...
Clarius Group LLC Raises Stake in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 5 days agoClarius Group LLC boosted its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 5.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The ...
Ads
related to: Enbrel